Home/Filings/4/0000950170-25-022654
4//SEC Filing

Elazzouzi Amy 4

Accession 0000950170-25-022654

CIK 0001501796other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 7:31 PM ET

Size

4.7 KB

Accession

0000950170-25-022654

Insider Transaction Report

Form 4
Period: 2025-02-18
Elazzouzi Amy
Senior Vice President, Finance
Transactions
  • Sale

    Common Stock

    2025-02-18$7.75/sh1,404$10,88182,278 total
Footnotes (1)
  • [F1]The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Documents

1 file

Issuer

Aura Biosciences, Inc.

CIK 0001501796

Entity typeother

Related Parties

1
  • filerCIK 0002042910

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 7:31 PM ET
Size
4.7 KB